This report provides an overview of the cases of hepatitis of unknown origin in children aged 16 years and below reported to ECDC and the WHO Regional Office for Europe through The European Surveillance System (TESSy).
The conference addressed long-term effectiveness HIV of drugs, co-infections with tuberculosis or viral hepatitis and other co-morbidities, and most inequitable access to care across Europe
2014, the topic of the conference was HIV and Viral Hepatitis: Challenges of Timely Testing and Care, and the main objectives were to provide the fields of HIV and viral hepatitis with the opportunity to learn from each other and to reflect on their experiences.
From 18 to 25 November 2016, almost 500 organisations all across Europe are hosting activities to increase awareness of the benefits of HIV and hepatitis testing.
From 18 to 25 November 2016, almost 500 organisations all across Europe hosted activities to increase awareness of the benefits of HIV and hepatitis testing.